Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 489


A neutralizing anti-G-CSFR antibody blocks G-CSF-induced neutrophilia without inducing neutropenia in nonhuman primates.

Scalzo-Inguanti K, Monaghan K, Edwards K, Herzog E, Mirosa D, Hardy M, Sorto V, Huynh H, Rakar S, Kurtov D, Braley H, Wilson N, Busfield S, Nash A, Andrews A.

J Leukoc Biol. 2017 May 17. pii: jlb.5A1116-489R. doi: 10.1189/jlb.5A1116-489R. [Epub ahead of print]


Combining nano-physical and computational investigations to understand the nature of "aging" in dermal collagen.

Ahmed T, Nash A, Clark KE, Ghibaudo M, de Leeuw NH, Potter A, Stratton R, Birch HL, Enea Casse R, Bozec L.

Int J Nanomedicine. 2017 Apr 21;12:3303-3314. doi: 10.2147/IJN.S121400. eCollection 2017.


Capturing Change: Creating a Template to Examine the Educational Experiences and Outcomes of the AONE Foundation Nurse Manager Fellowship.

Mackoff BL, Meadows MT, Nash A.

J Nurs Adm. 2017 Mar;47(3):179-187. doi: 10.1097/NNA.0000000000000462.


Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease.

Falkevall A, Mehlem A, Palombo I, Heller Sahlgren B, Ebarasi L, He L, Ytterberg AJ, Olauson H, Axelsson J, Sundelin B, Patrakka J, Scotney P, Nash A, Eriksson U.

Cell Metab. 2017 Mar 7;25(3):713-726. doi: 10.1016/j.cmet.2017.01.004. Epub 2017 Feb 9.


Emerging Evidence for a Direct Link between EAAT-Associated Anion Channels and Neurological Disorders.

Gonzalez-Suarez AD, Nash AI, Garcia-Olivares J, Torres-Salazar D.

J Neurosci. 2017 Jan 11;37(2):241-243. doi: 10.1523/JNEUROSCI.2947-16.2017. No abstract available.


Therapeutic Targeting of the G-CSF Receptor Reduces Neutrophil Trafficking and Joint Inflammation in Antibody-Mediated Inflammatory Arthritis.

Campbell IK, Leong D, Edwards KM, Rayzman V, Ng M, Goldberg GL, Wilson NJ, Scalzo-Inguanti K, Mackenzie-Kludas C, Lawlor KE, Wicks IP, Brown LE, Baz Morelli A, Panousis C, Wilson MJ, Nash AD, McKenzie BS, Andrews AE.

J Immunol. 2016 Dec 1;197(11):4392-4402. Epub 2016 Nov 2.


A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus.

Oon S, Huynh H, Tai TY, Ng M, Monaghan K, Biondo M, Vairo G, Maraskovsky E, Nash AD, Wicks IP, Wilson NJ.

JCI Insight. 2016 May 5;1(6):e86131.


Discussing sudden unexpected death in epilepsy: Are we empowering our patients? A questionnaire survey.

Keddie S, Angus-Leppan H, Parker T, Toescu S, Nash A, Adewunmi O, Liu R.

JRSM Open. 2016 Sep 1;7(9):2054270416654358. doi: 10.1177/2054270416654358. eCollection 2016 Sep.


Intra-molecular lysine-arginine derived advanced glycation end-product cross-linking in Type I collagen: A molecular dynamics simulation study.

Collier TA, Nash A, Birch HL, de Leeuw NH.

Biophys Chem. 2016 Nov;218:42-46. doi: 10.1016/j.bpc.2016.09.003. Epub 2016 Sep 13.


Crosstalk between insulin and dopamine signaling: A basis for the metabolic effects of antipsychotic drugs.

Nash AI.

J Chem Neuroanat. 2016 Jul 29. pii: S0891-0618(16)30069-2. doi: 10.1016/j.jchemneu.2016.07.010. [Epub ahead of print] Review.


Functions of the Alzheimer's Disease Protease BACE1 at the Synapse in the Central Nervous System.

Munro KM, Nash A, Pigoni M, Lichtenthaler SF, Gunnersen JM.

J Mol Neurosci. 2016 Nov;60(3):305-315. Epub 2016 Jul 25. Review.


Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.

Lane A, Metcalfe C, Young GJ, Peters TJ, Blazeby J, Avery KN, Dedman D, Down L, Mason MD, Neal DE, Hamdy FC, Donovan JL; ProtecT Study group..

BJU Int. 2016 Dec;118(6):869-879. doi: 10.1111/bju.13582. Epub 2016 Aug 17.


Houston Recovery Initiative: A Rich Case Study of Building Recovery Communities One Voice at a Time.

Bitting S, Nash A, Ochoa A.

J Addict Nurs. 2016 Apr-Jun;27(2):120-6. doi: 10.1097/JAN.0000000000000123.


The Alternative Peer Group: A Developmentally Appropriate Recovery Support Model for Adolescents.

Nash A, Collier C.

J Addict Nurs. 2016 Apr-Jun;27(2):109-19. doi: 10.1097/JAN.0000000000000122.


Computational study of glucosepane-water and hydrogen bond formation: an electron topology and orbital analysis.

Nash A, Saßmannshausen J, Bozec L, Birch HL, de Leeuw NH.

J Biomol Struct Dyn. 2017 Apr;35(5):1127-1137. doi: 10.1080/07391102.2016.1172026. Epub 2016 May 20.


Species Cross-Reactivity of Antibodies Used to Treat Ophthalmic Conditions.

Irani Y, Scotney P, Nash A, Williams KA.

Invest Ophthalmol Vis Sci. 2016 Feb;57(2):586-91. doi: 10.1167/iovs.15-18239.


Mapping intermolecular interactions and active site conformations: from human MMP-1 crystal structure to molecular dynamics free energy calculations.

Nash A, Birch HL, de Leeuw NH.

J Biomol Struct Dyn. 2017 Feb;35(3):564-573. doi: 10.1080/07391102.2016.1153521. Epub 2016 Apr 25.


CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors.

Panousis C, Dhagat U, Edwards KM, Rayzman V, Hardy MP, Braley H, Gauvreau GM, Hercus TR, Smith S, Sehmi R, McMillan L, Dottore M, McClure BJ, Fabri LJ, Vairo G, Lopez AF, Parker MW, Nash AD, Wilson NJ, Wilson MJ, Owczarek CM.

MAbs. 2016;8(3):436-53. doi: 10.1080/19420862.2015.1119352. Epub 2015 Dec 14.


Prospects for treatment of Porphyromonas gingivalis-mediated disease - immune-based therapy.

Reynolds EC, O'Brien-Simpson N, Rowe T, Nash A, McCluskey J, Vingadassalom D, Kleanthous H.

J Oral Microbiol. 2015 Sep 18;7:29125. doi: 10.3402/jom.v7.29125. eCollection 2015.


Susceptibility of bone marrow-derived macrophages to influenza virus infection is dependent on macrophage phenotype.

Campbell GM, Nicol MQ, Dransfield I, Shaw DJ, Nash AA, Dutia BM.

J Gen Virol. 2015 Oct;96(10):2951-60. doi: 10.1099/jgv.0.000240. Epub 2015 Jul 9.

Supplemental Content

Loading ...
Support Center